A critical discovery in cancer investigation is emerging with the use of nanobodies to re-engage mutated p53. This vital malignant inhibitor protein is frequently inactivated in several types of malignancies, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research